Cystectomy is medical phenomenon used in surgical procedures that is associated with the removal of all or part of the urinary bladder. The term cystectomy may also be applied to refer eradication of cyst or benign condition. The most average situation approving removal of urinary bladder is bladder cancer. Assessment of removed tissue after cystectomy and lymph node dissection assist in determination of pathological cancer staging. The detection of cancer staging further aids in diagnosis, treatment and follow-up required along with potential prognosis. According to world health organization’s statics for world cancer report nearly about 330,000 people across the globe every year suffer from bladder cancer. Although 50 per cent cases of them caused by smoking, relative risk is the same for non-smokers. Bladder cancer is more likely to affect men as compared to woman because they are more often exposed to cancer causing chemicals and intrinsically more susceptible.
Market Growth Factors
Increased prevalence of bladder cancer is the primary crucial driver of the market leading the market to grow. Moreover, poor life-style adoption, growing incidence of cyst, rupture of the bladder during accidental trauma and frequent smoking habits that releases cancer causing chemicals and radiation supports the market growth. On the other hand, high cost of the overall treatment and poor reimbursement policies restrain further growth of the market.
Get a Free Sample Report @ https://goo.gl/xMjNzP
The global Cystectomy market is done on the basis of type of cystectomy, methodology, equipment, end user and region. Depending on the type there are three main types of cystectomy performed. Radial cystectomy, partial cystectomy and simple cystectomy. Considering the methodology it is divided into open surgery, minimally invasive surgery and robotic surgery. By equipment division is done into general surgical instruments, diagnostic instruments, surgical robots and others. On the basis of end-user is classified into hospitals & clinics, urology centres and others.
The market is geographically segmented into-
• North America
o Rest of Europe
o South Korea
o Rest of Asia-Pacific
o South Africa
o Rest of the LAMEA
A developed economy North America is leading the market owing to high expenses on healthcare and proper reimbursement facilities along with adoption of new technology. Factors like increased awareness & large disposable income leads the European market on second position. Emerging countries like Asia Pacific is expected to record significant growth. Factor attributed to the growth of this region is future potential and new players entering the market. LAMEA is anticipated to witness moderate growth due to less knowledge about the medical development, poor economical & political conditions and low penetration in healthcare.
View Full Report @ https://goo.gl/QW7bSY
There are few players dominating the Cystectomy market which include-
- Richard Wolf Medical Instruments
- Intuitive Surgical Inc.
- Zephyr Surgical Implants
- Millennium Surgical Corp.
- Advanced Health Care Resources
- Boston Scientific Corporation
- Verb Surgical
- Titan Medical Inc.
Intuitive Surgical, Inc. is the global leader in robotic-assisted, minimally invasive surgery. On March 16th 2017 it announced that the U.S Food & Drug administration has provided 510 k clearances for the company’s da Vinci® Xi® Single-Site instruments and accessories. This technology enables surgeon to operate through a single incision in the patient’s umbilicus. Company’s da Vinci Si Surgical System has become the most prominent robotic-assisted single-port platform in the market.
Company Name: Garner Insights
Contact Person: Kevin Thomas
Phone: +1 513 549 5911